DEVA HOLDİNG A.Ş. Logo

DEVA HOLDİNG A.Ş.

Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.

DEVA | IS

Overview

Corporate Details

ISIN(s):
TRADEVAW91E2
LEI:
959800K5PD9GB1EHW234
Country:
Spain
Address:
AVDA CANTABRIA S / N, 28660 Boadilla del Monte
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1958, DEVA Holding A.Ş. is a prominent pharmaceutical manufacturer. The company's core business activities include the development, production, and marketing of a diverse portfolio of healthcare products. Its primary product lines consist of pharmaceuticals for human use, active pharmaceutical ingredients (APIs), veterinary medicines, and medical ampoules. DEVA Holding operates internationally, utilizing various business models such as distributorships, out-licensing, and supply agreements to market its products globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 13:03
Capital/Financing Update
Kupon ödemesi
English 27.6 KB
2025-11-07 16:20
Quarterly Report
Declaration of Responsibility.
Turkish 30.9 KB
2025-11-07 16:20
Management Discussion and Analysis
Activity Report
English 1.3 MB
2025-11-07 16:20
Management Discussion and Analysis
Activity Report
Turkish 1.3 MB
2025-11-07 16:20
Report Publication Announcement
Activity Report
English 11.8 KB
2025-11-07 16:19
Quarterly Report
Financial Report
Turkish 981.7 KB
2025-11-07 16:19
Annual / Quarterly Financial Statement
Financial Report
English 2.6 MB
2025-11-07 15:01
Capital/Financing Update
TRSDEVA82611 ISIN Kodlu tahvilin beşinci kupon faiz oranı hakkında.
English 27.7 KB
2025-11-05 11:32
Governance Information
Kurumsal Yönetim Bilgi Formu Güncelleme
English 34.6 KB
2025-11-05 08:10
Governance Information
Kurumsal Yönetim Bilgi Formu Güncelleme
Turkish 57.3 KB
2025-11-05 08:09
Board/Management Information
Company General Info Form
English 15.0 KB
2025-11-05 08:09
Board/Management Information
Yönetim Kurulu Komiteleri
Turkish 17.4 KB
2025-11-05 07:52
Governance Information
Bağımsız Yönetim Kurulu Üyesi tescili
Turkish 483.4 KB
2025-11-05 07:52
Board/Management Information
Bağımsız Yönetim Kurulu Üyesi tescili
Turkish 300.7 KB
2025-11-05 07:52
Board/Management Information
Bağımsız Yönetim Kurulu Üyesi tescili
Turkish 17.5 KB

Automate Your Workflow. Get a real-time feed of all DEVA HOLDİNG A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DEVA HOLDİNG A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DEVA HOLDİNG A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.